Viewing Study NCT00082134


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-29 @ 1:23 PM
Study NCT ID: NCT00082134
Status: COMPLETED
Last Update Posted: 2015-03-05
First Post: 2004-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module